Long-term clinical performance of AAI pacing in patients with sick sinus syndrome: A comparison with dual-chamber pacing

Hiroshi Masumoto, Yuichi Ueda, Rinya Kato, Akihiko Usui, Takashi Maseki, Yasushi Takagi, Masato Usui

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Aims: In this clinical study, we compared two groups of age-matched patients, AAI and DDD, to evaluate the clinical benefits of AAI pacing in patients with sick sinus syndrome (SSS) and normal atrioventricular (AV) conduction. Methods and results: Ninety-five patients with SSS implanted with AAI pacemakers were compared with 101 SSS patients implanted with DDD pacemakers. Mortality, chronic atrial fibrillation, lead survival rates, and reoperation rates were compared by Kaplan-Meier analysis. Eight AAI devices were switched to DDD due to high-degree (grade 2-3) AV block. The incidence of high-degree AV block was 1.104%/year, with a freedom rate of 88.6% at 10 years. There were no significant differences between the two groups in survival rates (87.8% in AAI vs. 93.4% in DDD at 10 years), freedom from atrial fibrillation (93.6% vs. 90.6%), or freedom from reoperation (71.3% vs. 76.3%). On the other hand, lead failure was twice as frequent in the DDD group than in the AAI group (relative risk=2.045, P=0.0382). Conclusion: AAI pacing, a simple system using a single lead and single-chamber pacemaker, can achieve a clinical outcome similar to that of the DDD mode in patients with SSS and normal AV conduction.

Original languageEnglish
Pages (from-to)444-450
Number of pages7
JournalEuropace
Volume6
Issue number5
DOIs
Publication statusPublished - 01-09-2004
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Long-term clinical performance of AAI pacing in patients with sick sinus syndrome: A comparison with dual-chamber pacing'. Together they form a unique fingerprint.

  • Cite this